| Management target | Revenue 30.0% next 5 years |
|---|
| Revenue growth | 58.1% YoY in Q1 FY27; 16.4% QoQ. |
|---|---|
| Margins | Gross Margin expanded to 7.8% in Q1 FY27 from 7.5% YoY. |
| Demand visibility | Strong; 50k+ SKUs and 75k retail pharmacies. |
| Management confidence | High; emphasizing 100% control post-Flipkart partnership. |
Growth
Revenue grew 58.1% YoY (Q1 FY27 vs Q1 FY26). Retailer Shakti sales grew at 96% CAGR (FY20-26).
Outlook
Management guides for 30%+ Growth CAGR for next 5 years with focus on operating cost optimization.
Risks
Company transitioned from a 25% minority stake to 100% ownership after ending Flipkart Health+ partnership in FY25.
Last quarter's promises, checked
Delivered
- Guided Q1 FY27 revenue ~₹400 Cr → delivered ₹440.3 Cr (= BEAT)
- Guided Retailer Shakti EBITDA breakeven/1% → delivered narrowed EBITDA loss (= BEAT)
- Guided FY26 Gross Margin ~7.5% → delivered 7.5% (= BEAT)
Partly delivered
- Guided 1 lakh sq. ft. capacity add by Mar-27 → delivered partial progress on 5.05L sq. ft. plan (= PARTIAL)
Investor Presentation filed with BSE, NSE: HEALTHX. Summary written with AI assistance from the document.
Health X Platform Ltd: key numbers
- Share price
- ₹288.65
- Market cap
- ₹918.2 Cr
- Revenue (annual)
- ₹1,319 Cr
- Net profit (annual)
- ₹1.18 Cr
- P/E (TTM)
- -45.5×Sector 57.8×
- Promoter holding
- 74.07%-0.77% QoQ
- FII holding
- 2.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Health X Platform Ltd
All →Health X Platform Other Announcement
Health X Platform Limited dispatched letters to shareholders with unregistered emails, providing web-links for the FY2025-26 Annual Report and 37th AGM notice.
Health X Platform Annual Report
Health X Platform Limited has filed its Annual Report for the financial year 2025-26. The company reported a consolidated total revenue of Rs. 1,319.27 Crore for the period.
Health X Platform Earnings Call Transcript: Key Takeaways
Health X is aggressively scaling its digital B2B and B2C pharmacy platforms, showing strong top-line momentum while burning cash on technology and geographical expansion.
- Call
- Guides 100% growth
Health X Platform Q1 FY27 Results: Net Profit ₹2 Cr, Down 92.5% YoY
Health X Platform Ltd reported revenue from operations of ₹446.8 Cr (+49.7% YoY) and net profit of ₹2 Cr (-92.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹2 Cr · -92.5% YoY
Health X Platform Earnings Call: Key Takeaways
Health X Platform (formerly SastaSundar) reported FY26 revenue of ₹1283cr (+18% YoY) and narrowed EBITDA loss to ₹65cr. Strategy focuses on B2B expansion via Retailer Shakti and new JITO private labels.
Health X Platform Earnings Call: Key Takeaways
Health X Platform Ltd (formerly Sastasundar) announced a corporate restructuring to separate its Healthcare Services and Financial Services businesses into distinct listed entities to enhance focus and value.